Has Andrew Pierce, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,427 in general payments to Andrew Pierce, MD across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Pierce, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Pierce, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Pierce, MD

Psychiatry · Murfreesboro, TNNPI 1235578717

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Johnson & Johnson at 28.2% of the total. Reporting peaked in 2019 at $667 and has fallen 94.2% since, to $39 in 2025.

$1,427in general payments, 2019–2025

Across 77 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$403
Otsuka America Pharmaceutical, Inc.$230
Vanda Pharmaceuticals Inc.$201
Neurocrine Biosciences, Inc.$137
Lundbeck LLC$84
Alkermes, Inc.$74
plus $298 from 11 others

What the payments were for

Food & beverage$1,427100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	21	$403
Otsuka America Pharmaceutical, Inc.	13	$230
Vanda Pharmaceuticals Inc.	9	$201
Neurocrine Biosciences, Inc.	7	$137
Lundbeck LLC	5	$84
Alkermes, Inc.	4	$74
Takeda Pharmaceuticals U.S.A., Inc.	2	$43
AbbVie	3	$42
Axsome Therapeutics, Inc.	2	$39
Eisai Inc.	2	$31
Sunovion Pharmaceuticals Inc.	2	$30
Bausch Health US, LLC	2	$29
Avanir Pharmaceuticals, Inc.	1	$24
Validus Pharmaceuticals LLC	1	$21
Neos Therapeutics, LP	1	$15
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$13
Neuronetics, Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRAVATO$120

How this compares

$1,427 in reported general payments places this provider in the 70th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee →

Medicare billing

Part B allowed, 2024

$45,993

Medicare patients

232

Services billed

586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Chlorpromazine Hcl	32	$19,383
Quetiapine Fumarate	321	$7,493
Naltrexone Hcl	29	$6,364
Divalproex Sodium	57	$5,305
Ziprasidone Hcl	37	$4,390
Mirtazapine	119	$4,202
Memantine Hcl	90	$3,777
Divalproex Sodium ErDivalproex Sodium	42	$3,385
Donepezil Hcl	180	$2,787
Fluvoxamine Maleate	17	$2,190
Sertraline Hcl	144	$2,131
Risperidone	128	$1,848
Oxcarbazepine	20	$1,789
Fluoxetine Hcl	116	$1,639
Buspirone Hcl	81	$1,636

Paid to pharmacies, not to this prescriber.

Other psychiatry in Murfreesboro

Hannah StreetMurfreesboro$8K
Samuel OkpakuMurfreesboro$7K
Ravi SinghMurfreesboro$6K
Rakesh AminNashville$3M
Brian BonfardinJohnson City$2.6M
John FenleyJohnson City$1.4M
David SnowMaryville$605K
Karthi NamasivayamKnoxville$225K
Robert JamiesonNashville$141K
George BrownJohnson City$91K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →